DCTY1102 Injection

· Beijing DCTY Biotech Co.,Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DCTY1102 Injection, covering 2025-06-11 to 2025-06-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DCTY1102 Injection in Patients With Advanced Solid Tumors [Phase 1]